0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Malignant - How Bad Policy and Bad Evidence Harm People with Cancer (Hardcover) Loot Price: R786
Discovery Miles 7 860
Malignant - How Bad Policy and Bad Evidence Harm People with Cancer (Hardcover): Vinayak K. Prasad

Malignant - How Bad Policy and Bad Evidence Harm People with Cancer (Hardcover)

Vinayak K. Prasad

 (sign in to rate)
Loot Price R786 Discovery Miles 7 860 | Repayment Terms: R74 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

How hype, money, and bias can mislead the public into thinking that many worthless or unproven treatments are effective. Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel-but what is often missing from the popular narrative is that, far too often, these new drugs have marginal or minimal benefits. Some are even harmful. In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced. Throughout this work, Prasad illuminates deceptive practices which * promote novel cancer therapies long before credible data are available to support such treatment; and * exaggerate the potential benefits of new therapies, many of which cost thousands and in some cases hundreds of thousands of dollars. Prasad then critiques the financial conflicts of interest that pervade the oncology field, the pharmaceutical industry, and the US Food and Drug administration. This is a book about how the actions of human beings-our policies, our standards of evidence, and our drug regulation-incentivize the pursuit of marginal or unproven therapies at lofty and unsustainable prices. Prasad takes us through how cancer trials are conducted, how drugs come to market, and how pricing decisions are made, asking how we can ensure that more cancer drugs deliver both greater benefit and a lower price. Ultimately, Prasad says, * more cancer clinical trials should measure outcomes that actually matter to people with cancer; * patients on those trials should look more like actual global citizens; * we need drug regulators to raise, not perpetually lower, the bar for approval; and * we need unbiased patient advocates and experts. This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer-and how we can avoid repeating the policy and practice mistakes of the past.

General

Imprint: Johns Hopkins University Press
Country of origin: United States
Release date: April 2020
Authors: Vinayak K. Prasad (Assistant Professor of Medicine)
Dimensions: 229 x 152 x 25mm (L x W x T)
Format: Hardcover
Pages: 304
ISBN-13: 978-1-4214-3763-7
Categories: Books > Law > Laws of other jurisdictions & general law > Social law > Public health & safety law
Books > Health, Home & Family > Family & health > Popular medicine > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 1-4214-3763-5
Barcode: 9781421437637

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Biomarkers in Cancer Detection and…
Ranbir Chander Sobti, Masatoshi Watanabe, … Paperback R3,268 Discovery Miles 32 680
Targeted Nanomedicine for Breast Cancer…
Shivani Rai Paliwal, Rishi Paliwal Paperback R4,491 Discovery Miles 44 910
Encyclopedia of Infection and Immunity
Nima Rezaei Hardcover R58,452 Discovery Miles 584 520
Bone Cancer - Bone Sarcomas and Bone…
Dominique Heymann Hardcover R5,123 Discovery Miles 51 230
Foundations of Colorectal Cancer
Alejandro Pazos Sierra Paperback R4,538 Discovery Miles 45 380
Immunotherapy in Resistant Cancer: From…
Jorge Morales Montor, Mariana Segovia Hardcover R3,506 Discovery Miles 35 060
Nanotechnology Applications for Cancer…
Sanyog Jain, Kaisar Raza, … Paperback R4,059 Discovery Miles 40 590
Nano Drug Delivery Strategies for the…
Awesh K. Yadav, Umesh Gupta, … Paperback R3,503 Discovery Miles 35 030
Sphingolipids in Cancer, Volume 140
Charles E. Chalfant, Paul B. Fisher Hardcover R3,743 Discovery Miles 37 430
Lung Cancer, An Issue of…
Roy S. Herbst, Daniel Morgensztern Hardcover R2,125 Discovery Miles 21 250
Adjunctive Rehabilitation Approaches to…
Andrea L. Cheville Hardcover R2,127 Discovery Miles 21 270
Pediatric Brain Tumors Update, An Issue…
Lara Brandao Hardcover R2,143 Discovery Miles 21 430

See more

Partners